It was found that the expression of S100A9 was higher in HBV-positive HCC tissues than in HBV-negative tissues, and silencing S100A9 expression blocked HBx (HBV encoded X protein)-induced growth and metastasis of HepG2 cells in vitro and in vivo. The gene discussed is S100A9; the disease is hepatocellular carcinoma.